Benign Prostatic Hyperplasia Therapeutics Market size was valued at USD 7.5 Billion in 2024 and is forecasted to grow at a CAGR of 6.2% from 2026 to 2033, reaching USD 12.3 Billion by 2033.
South Korea’s Benign Prostatic Hyperplasia Therapeutics Market: Evolving Treatment Patterns and Industry Demands
In South Korea, the Benign Prostatic Hyperplasia (BPH) therapeutics market has witnessed significant shifts in treatment approaches over recent years. Notably, from 2012 to 2016, drug therapy emerged as the predominant treatment method, accounting for approximately 98.77% of cases. Among these, α-blocker monotherapy was the most commonly prescribed, highlighting a preference for less invasive treatment options among patients and healthcare providers.
Interestingly, while traditional surgical procedures like Transurethral Resection of the Prostate (TURP) were once standard, their usage has seen a decline. Conversely, Holmium Laser Enucleation of the Prostate (HoLEP) has gained traction, increasing from 19.4% to 39.7% during the same period. This shift underscores a growing inclination towards minimally invasive surgical techniques that offer reduced recovery times and fewer complications.
From an industry perspective, these evolving treatment preferences necessitate adaptations in pharmaceutical and medical device sectors. The demand for effective α-blockers and combination therapies has surged, prompting pharmaceutical companies to innovate and expand their product lines. Simultaneously, the rise in HoLEP procedures has spurred interest in advanced laser technologies and training programs for urologists, ensuring they are equipped to perform these specialized surgeries.
Moreover, the increasing prevalence of BPH, particularly among the aging male population, has amplified the need for accessible and efficient treatment options. This demographic trend presents both challenges and opportunities for the healthcare industry, emphasizing the importance of patient-centric approaches and continuous research to enhance therapeutic outcomes.
In conclusion, South Korea's BPH therapeutics market is undergoing a transformative phase, characterized by a shift towards pharmacological treatments and minimally invasive surgical procedures. Industries involved must stay attuned to these changes, ensuring they meet the evolving needs of patients and healthcare professionals alike.
Get an In-Depth Research Analysis of the South Korea Benign Prostatic Hyperplasia Therapeutics Market Size And Forecast [2025-2032]
Abbott Laboratories
Allergan plc
Astellas Pharma
Boehringer Ingelheim Pharma GmbH & Co. KG
Eli Lilly and Company
GlaxoSmithKline plc
Merck & Co.
Pfizer
Sanofi
Teva Pharmaceutical Industries Limited
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Benign Prostatic Hyperplasia Therapeutics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Benign Prostatic Hyperplasia Therapeutics Market
Alpha Blockers
5-Alpha Reductase Inhibitors
Phosphodiesterase-5 Inhibitors
Combination Therapies
Oral
Injectable
Topical
Age Groups
Gender
Early Stage Treatment
Moderate Stage Treatment
Severe Stage Treatment
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Benign Prostatic Hyperplasia Therapeutics Market Research Analysis
1. Introduction of the South Korea Benign Prostatic Hyperplasia Therapeutics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Benign Prostatic Hyperplasia Therapeutics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Benign Prostatic Hyperplasia Therapeutics Market, By Type
6. South Korea Benign Prostatic Hyperplasia Therapeutics Market, By Application
7. South Korea Benign Prostatic Hyperplasia Therapeutics Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Benign Prostatic Hyperplasia Therapeutics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/